US Medicare rules on insulin pump coverage
This article was originally published in Clinica
Executive Summary
Medicare has decided it generally will not cover use of an implantable insulin pump to treat insulin-dependent persons with type II diabetes. Rather than ruling on the pump itself, the agency ruled on a Medtronic request that it no longer rely on the results of a peptide C test to determine whether or not a person should qualify for the pump.